Best Peptides for Fat Loss

The Shift in the Fat Loss Game

If we were having this conversation five years ago, my answer about fat loss peptides would have been very different. Back then, we were talking almost exclusively about growth hormone secretagogues and trying to squeeze single-digit body fat percentages out of subtle metabolic shifts. We were playing in the margins.

Then the GLP-1 receptor agonists hit the mainstream, and the entire paradigm shifted.

Today, we have peptides that don't just help you mobilize a little extra stored fat during fasted cardio. We have peptides that fundamentally rewrite how your brain perceives hunger and how your body handles insulin. But here is the catch: because these new drugs are so effective, people have forgotten about the older peptides that actually excel at building muscle and targeting specific types of stubborn fat.

If you want to choose the right peptide protocol, you have to understand the difference between dropping scale weight and changing your body composition. A 20-pound weight loss means nothing if 10 pounds of it was contractile muscle tissue. We need to talk about which peptides suppress appetite, which ones actually burn fat, and which ones protect your hard-earned muscle.

The Appetite Assassins: GLP-1 and GIP Agonists

Let's start with the heavyweights. When people ask me for the "best peptide for fat loss" right now, what they usually want is Semaglutide or Tirzepatide.

These aren't "fat burners" in the traditional sense. They don't spike your heart rate or make you sweat through your t-shirt like the sketchy stimulants we used in the early 2000s. Instead, they work primarily by mimicking incretin hormones—naturally occurring peptides that your gut releases when you eat.

They delay gastric emptying, meaning food literally sits in your stomach longer. More importantly, they cross the blood-brain barrier and hit the hypothalamus, essentially telling your brain, "We are stuffed. Put the fork down."

Semaglutide: The Benchmark Semaglutide (often known by brand names Wegovy or Ozempic) targets a single receptor: GLP-1. The clinical data here is staggering. In the STEP clinical trials, participants lost an average of 14.9% of their body weight over 68 weeks. If you weigh 200 pounds, that's nearly 30 pounds of tissue.

But Semaglutide has a reputation for being a bit of a blunt instrument. The nausea can be brutal for some users, and the fatigue is a widely reported side effect. You will lose weight, but you might not feel like hitting heavy squats while doing it.

Tirzepatide: The Upgrade Tirzepatide is a dual-agonist. It targets both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor.

Adding GIP to the mix changes everything. GIP seems to blunt the nausea commonly associated with GLP-1 activation while simultaneously enhancing insulin sensitivity and fat utilization. In the SURMOUNT-1 trials, users on the highest dose of Tirzepatide lost a staggering 20.9% of their body weight.

Frankly, from what I've seen in both the literature and the real world, Tirzepatide is superior to Semaglutide in almost every metric. Better weight loss, fewer side effects, better tolerability. If you have significant weight to lose (20+ pounds), this is currently the gold standard.

Retatrutide: The Future Retatrutide isn't fully approved yet, but it's a triple-agonist targeting GLP-1, GIP, and Glucagon receptors. Glucagon is the hormone that pulls stored glucose out of your liver and actually increases your basal metabolic rate. Phase 2 trial results showed an unheard-of 24.2% weight loss in 48 weeks. It literally forces your body to burn more energy at rest. Keep an eye on this one.

The Heavy Hitters Compared

Here is how the top-tier weight loss peptides stack up against each other based on current clinical data:

*(Phase 2 trial data)

The Body Recomp Specialists: GH Secretagogues

Here is the problem with GLP-1s: they are catabolic. When you starve your body, it doesn't just burn fat; it burns muscle. This is where Growth Hormone (GH) secretagogues come in.

Peptides like CJC-1295 and Ipamorelin don't kill your appetite. In fact, some of them might slightly increase it. What they do is stimulate your pituitary gland to release your own natural pulses of growth hormone.

Growth hormone is highly lipolytic—it tells your body to release stored fatty acids into the bloodstream to be used for energy. It also signals your body to preserve amino acids and protect muscle tissue.

If you are already relatively lean (say, 15% body fat for a man or 23% for a woman) and you want to drop those last five pounds of fat while maintaining your bench press, Semaglutide is the wrong tool. A blend of CJC-1295 and Ipamorelin is the right tool. You run it for 12 weeks, keep your diet dialed in, and you end up looking harder, denser, and leaner.

Tesamorelin: The Visceral Fat Killer We have to single out **Tesamorelin** here. This is a very specific growth hormone-releasing hormone (GHRH) analogue that is FDA-approved specifically to reduce visceral fat in HIV patients (a condition called lipodystrophy).

Visceral fat is the hard, dangerous fat that packs itself around your organs. It's what gives older men that hard "beer belly" look even if their arms are skinny. Clinical trials show Tesamorelin cuts visceral fat by up to 18%. It is incredibly effective at what it does. The downside? It's expensive, and because it spikes GH so aggressively, you have to watch your fasting blood glucose levels, as elevated GH can temporarily reduce insulin sensitivity.

The Highly Marketed Disappointment: AOD-9604

I promised you opinions backed by data, so let's talk about AOD-9604.

AOD stands for "Anti-Obesity Drug." It is a fragment of the human growth hormone molecule (specifically amino acids 176-191). The theory was brilliant: isolate the part of the growth hormone molecule responsible for fat burning, and cut out the parts that affect insulin and IGF-1.

Clinics push this stuff relentlessly. They charge a fortune for it.

But look at the human data. The developer, Metabolic Pharmaceuticals, ran multiple clinical trials on AOD-9604 in the 2000s. Six trials. Over 900 patients. The result? It failed to show clinically significant weight loss compared to a placebo. The company literally abandoned the drug for obesity treatment in 2007.

Does it work in rats? Yes. Does it seem to help with cartilage repair in osteoarthritis? Actually, yes, there is some cool emerging data there. But as a primary fat loss tool for humans? The hype here completely outpaces the evidence. Save your money and buy better food.

The Cellular Engine Upgrades: MOTS-c

If you are an intermediate or advanced peptide user and you've already optimized your diet and training, mitochondrial peptides are the next frontier.

MOTS-c (Mitochondrial Derived Peptide) is utterly fascinating. Instead of acting on your brain or your pituitary gland, it acts directly on your mitochondria. It activates the AMPK pathway.

Think of AMPK as your body's master energy switch. When you do high-intensity interval training or lift heavy weights, AMPK turns on and tells your cells to start burning fat for fuel. MOTS-c essentially flips this switch pharmacologically. Researchers literally call it an "exercise mimetic."

In animal studies, mice given MOTS-c stay lean even when fed a high-fat diet, and their physical endurance skyrockets. In humans, users report a massive increase in workout capacity and steady, sustainable fat loss. It's usually run in short, intense bursts (e.g., a 4-week cycle) rather than the long, multi-month protocols used for GLP-1s.

How to Sequence Your Protocol

People ask me all the time if they should stack these. My advice is usually to sequence them instead.

If you are 40 pounds overweight, a GH secretagogue isn't going to move the needle enough for you to notice. You start with Tirzepatide or Semaglutide. You use the appetite suppression to fix your relationship with food, drop the bulk of the adipose tissue, and get your insulin sensitivity back to a healthy baseline.

Once you are within striking distance of your goal weight, the GLP-1 fatigue often sets in, and you run the risk of looking "skinny-fat." That is the exact moment you taper off the GLP-1 and transition to a CJC-1295/Ipamorelin protocol to protect your muscle mass, restore your energy, and tighten up your body composition.

Where This Leaves Us

We finally have compounds that solve the physiological roadblocks of fat loss. But you have to pick the right tool for the job.

If you need to drop significant scale weight and struggle with portion control, Tirzepatide is currently the undisputed king of the hill, with Semaglutide acting as a highly effective, slightly less tolerable backup.

If you are already in decent shape and want to drop visceral fat or recomp your physique without losing muscle, Tesamorelin or a CJC/Ipamorelin blend is where you should spend your money.

Ignore the marketing fluff around AOD-9604, ensure you are buying from sources with strict third-party testing, and remember that no peptide out-works a terrible diet. They are biological force multipliers. You still have to provide the force.